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Exposure to fine particulate air pollution
[aerodynamic diameter < 2.5 µm (PM2.5)] is
associated with increased cardiopulmonary
mortality (Pope et al. 2002; Samet et al.
2000). Coronary ischemic events, occurring
as rapidly as 1–2 hr after exposure, account
for a major portion of this heightened mortal-
ity (Peters et al. 2001, 2004; Pope et al.
2004). In addition, an enhanced risk for
acute cerebrovascular strokes has been linked
to particulate air pollution (Hong et al. 2002;
Tsai et al. 2003).
Several biologic mechanisms have been
demonstrated that may in part explain these
ﬁndings (Brook et al. 2003), including acute
arterial vasoconstriction after exposure to con-
centrated ambient fine particles (CAP) with
added ozone (Brook et al. 2002). In the latter
study (Brook et al. 2002), subjects exposed to
CAP with a higher organic carbon content
had greater vasoconstriction than did those
subjects exposed to CAP with less organic car-
bon content (Urch et al. 2004). Considering
that PM2.5 has also been shown to alter auto-
nomic balance (Devlin et al. 2003; Gold et al.
2000; Magari et al. 2001), it is reasonable to
hypothesize that air pollution exposure can
meaningfully affect blood pressure (BP). Using
a randomized, sham [particle-free air (PFA)
without added O3] controlled study, we inves-
tigated the effect of short-term inhalation of
CAP with added O3 (CAP+O3) on BP and
heart rate (HR) measured during exposure.
Materials and Methods
Study participants. BP and HR were measured
in healthy individuals at 30-min intervals dur-
ing 2-hr controlled exposures carried out at the
Gage Occupational and Environmental Health
Unit. Measurements were included from two
randomized CAP exposure studies (studies A
and B) with identical exposure protocols but
different cardiorespiratory outcome measures.
We report data for the exposures that were
common to both studies, 150 µg/m3 CAP+O3
and PFA. Twenty-one subjects were included
from study A. We have previously reported BP
data from this study (Brook et al. 2002), meas-
ured immediately before and 10–20 min after
CAP+O3 exposure, which showed no signiﬁ-
cant changes in systolic BP (SBP) or diastolic
BP (DBP). Two subjects were also included
from study B (which included both respiratory
and vascular measures in individuals exposed
to CAP±O3) who had complete data for both
exposures. Therefore, 23 individuals (21 from
study A and 2 from study B) had both treat-
ments. Exposures were a minimum of 1 day
apart, and the median interval between expo-
sures was 1 week. Both studies had prior
approval from the human subjects research
ethics review committees of the University of
Toronto and St. Michael’s Hospital; all partici-
pants gave written informed consent before
enrollment. Healthy 18- to 50-year-old non-
smokers were enrolled who met the following
criteria: no cardiovascular disease or diabetes,
normotensive (100/50 < BP < 140/90 mm
Hg), not using lipid-lowering medications or
inhaled/oral corticosteroids, and free of upper
respiratory tract infections for at least 3 weeks
before exposure testing.
Exposure protocol. To reduce the impact
of diurnal variation, subjects arrived at the lab
around 0900 hr for each exposure. Each sub-
ject underwent a vascular and respiratory
work-up of approximately 1 hr followed
immediately by a 2-hr exposure to either
CAP+O3 or PFA using a facemask delivery.
During exposure, subjects were asked to list
any symptoms that they had, and immediately
afterward, they were asked if they thought
that they were exposed to a pollutant. Subjects
were blind to the two exposure treatments.
CAP exposures were produced with a high-
flow virtual impactor system, using fine PM
(PM2.5) drawn from outside the laboratory;
O3 produced by an arc generator was added
upstream of the particle concentrator. During
PFA exposures, a HEPA ﬁlter was inserted in-
line downstream of the particle concentrator.
The human exposure facility and exposure
characterization have been described in detail
elsewhere (Petrovic et al. 2000; Urch et al.
2004).
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Exposure to air pollution has been shown to cause arterial vasoconstriction and alter autonomic
balance. Because these biologic responses may inﬂuence systemic hemodynamics, we investigated
the effect of air pollution on blood pressure (BP). Responses during 2-hr exposures to concen-
trated ambient ﬁne particles (particulate matter < 2.5 µm in aerodynamic diameter; PM2.5) plus
ozone (CAP+O3) were compared with those of particle-free air (PFA) in 23 normotensive, non-
smoking healthy adults. Mean concentrations of PM2.5 were 147 ± 27 versus 2 ± 2 µg/m3, respec-
tively, and those of O3 were 121 ± 3 versus 8 ± 5 ppb, respectively (p < 0.0001 for both). A
signiﬁcant increase in diastolic BP (DBP) was observed at 2 hr of CAP+O3 [median change, 6 mm
Hg (9.3%); binomial 95% conﬁdence interval (CI), 0 to 11; p = 0.013, Wilcoxon signed rank test]
above the 0-hr value. This increase was signiﬁcantly different (p = 0.017, unadjusted for basal BP)
from the small 2-hr change during PFA (median change, 1 mm Hg; 95% CI, –2 to 4; p = 0.24).
This prompted further investigation of the CAP+O3 response, which showed a strong association
between the 2-hr change in DBP (and mean arterial pressure) and the concentration of the organic
carbon fraction of PM2.5 (r = 0.53, p < 0.01; r = 0.56, p < 0.01, respectively) but not with total
PM2.5 mass (r ≤ 0.25, p ≥ 0.27). These ﬁndings suggest that exposure to environmentally relevant
concentrations of PM2.5 and O3 rapidly increases DBP. The magnitude of BP change is associated
with the PM2.5 carbon content. Exposure to vehicular trafﬁc may provide a common link between
our observations and previous studies in which trafﬁc exposure was identiﬁed as a potential risk fac-
tor for cardiovascular disease. Key words: air pollution, blood pressure, hypertension, ozone, partic-
ulate matter, PM2.5. Environ Health Perspect 113:1052–1055 (2005). doi:10.1289/ehp.7785
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highly variable, and even minor alterations in
temperature and physical activity can substan-
tially alter readings (Parati et al. 2003). In
order to minimize effects not mediated by air
pollution, BP and HR were measured through-
out the actual exposure period while subjects
were resting quietly and at constant tempera-
ture (~ 23°C). Participants were provided with
an automated oscillometric BP monitor
(Oscar-1; SunTech Medical Instruments, Inc.,
Raleigh, NC, USA) immediately before enter-
ing the exposure enclosure, with the arm-cuff
secured on their left upper arm. In addition, a
PC-based real-time 12-lead electrocardiogram
(ECG; PC-ECG 1200; Norav Medical Ltd.,
Kiryat Bialik, Israel) was connected. After sit-
ting inside the exposure enclosure, the door
was sealed and concentrator pumps turned on.
When resting quietly, subjects were asked to
place their left forearm on their left leg and
then turn on the BP monitor with their right
hand (0 hr baseline exposure measure). BP
measures were repeated at 30-min intervals
during exposure, with the final BP measure-
ment made at 2 hr, immediately before the end
of the exposure. HR was determined at 30-min
intervals by the 12-lead ECG. The technician
recording the BP and HR was blinded to the
exposure treatments (CAP+O3 vs. PFA).
Statistical methods. Intraexposure com-
parisons of BP (SBP, DBP, mean) and HR
outcome variables were made using a 0-hr
value as the baseline reference to assess the
change over the course of the 2-hr exposure.
The respective exposure values at 2 hr were
calculated as a linear change (∆ = 2 hr – 0 hr)
for each participant. The nonparametric
Wilcoxon signed rank test was used to com-
pare the difference in the 0- to 2-hr change
between the two exposure treatments and was
conﬁrmed using percentage change, as well as
the slopes of the individual straight lines ﬁtted
over the five 30-min measurements. Further
support was provided by Student’s t-test of the
linear and percentage changes and by a
repeated-measures analysis of the linear trend
over time. Linear regression analysis was also
used to estimate the slope of the relationship
between the 2-hr change in BP (SBP, DBP,
mean) and the concentration of individual PM
constituents (organic and elemental carbon,
inorganic ions, and trace elements) as well as
the total mass concentration. PM constituent
measurements have previously been described
(Urch et al. 2004). An unpaired t-test was used
for interexposure comparisons of the mean
PM2.5, O3, and environmental values. The
Wilcoxon signed rank test was used for inter-
exposure comparison of the number of symp-
toms reported during exposure. All analyses
were performed using SAS for Windows
(release 8.02; SAS Institute Inc., Cary, NC,
USA).
Results
The participants ranged in age from 19 to
50 years, with a mean (± SD) age of 32 ±
10 years, and included 13 males and
10 females (Table 1).
The mean exposure concentration (± SD)
of the PM2.5 total mass was 147 ± 27 with a
range of 102–214 µg/m3 (Table 2). The
mean O3 concentration was less variable, with
a mean (± SD) of 121 ± 3 and range of
115–128 ppb. As expected, the PM2.5 total
mass and O3 concentrations were signiﬁcantly
different between exposure treatments
(p < 0.0001 for both). The exposure concen-
trations of the other copollutants measured,
which included nitrogen oxides, sulfur diox-
ide, and carbon monoxide, were low and less
than measured ambient levels. There were no
significant treatment differences for any of
these copollutants, for temperature, or for
relative humidity.
Symptoms reported by subjects during
exposures were few, if any (mean number of
symptoms reported ± SD was 1.0 ± 1.9 for
CAP+O3 vs. 0.5 ± 1.2 for PFA; p = 0.039).
For example, only 4 of 23 subjects (17%)
reported smelling an odor during CAP+O3
exposure, compared with 1 during PFA,
which is not surprising because the O3 genera-
tion began at the exposure start (time 0 hr)
and progressively increased over the first
10 min, then remained stable at 120 ppb over
the duration of the exposure. Subjects were
not able to identify the pollutant (CAP+O3)
exposure with any precision, because only
52% (12 of 23) responded “yes” immediately
afterward to the question, “Do you think you
were exposed to a pollutant?” After PFA expo-
sure, 30% (7 of 23) responded “yes” they were
exposed to a pollutant, including 4 of the 12
who said “yes” after CAP+O3.
Table 3 shows the median DBP and SBP
values over the course of CAP+O3 and PFA
exposures. The last column shows the 0- to
2-hr linear change. DBP showed a progressive
trend to increase over time during CAP+O3
exposure, from a 0-hr baseline, compared
with a ﬂat response during PFA. A signiﬁcant
2-hr increase of 6 mm Hg (binomial 95% CI,
0–11; p = 0.013), or 9.3% above the 0-hr
value, was observed during CAP+O3 expo-
sure. This increase was signiﬁcantly different
(p = 0.017, unadjusted for basal BP) from the
small, nonsigniﬁcant, 1 mm Hg (95% CI, –2
to 4) change observed during PFA. Analyses
using percent change and slope as end points,
as well as parametric analyses, supported these
ﬁndings. There were no signiﬁcant changes of
SBP, mean arterial pressure (MAP; 2/3 DBP
+ 1/3 SBP), or HR during either exposure.
The observed changes in DBP prompted
us to look more closely at which constituents
of the CAP may be responsible. Figure 1 sug-
gests a nonlinear relationship between the
individual 2-hr linear changes in DBP during
CAP+O3 exposure and the estimated exposure
concentration of organic carbon. Indeed, the
strongest association was found with the loge
(ln) concentration of organic carbon (r = 0.53,
p = 0.009), much stronger, for example, than
with PM2.5 total mass (r = 0.25, p = 0.27). For
these individuals, the mean total carbon
(organic + elemental carbon) fraction of the
PM2.5 total mass was 28.4 ± 13.3 µg/m3
(range, 11.4–56.5), of which the majority,
25.0 ± 11.6 µg/m3, was organic carbon. There
was also a signiﬁcant correlation for the 2-hr
change in MAP and the ln concentration of
organic carbon (r = 0.56, p = 0.006) but,
again, much weaker with total mass (r = 0.21,
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Table 1. Participant characteristics (n = 23; 13 male
and 10 female).
Characteristic Mean ± SD
Age (years) 32 ± 10
Height (cm) 173 ± 8
Weight (kg) 72 ± 11
SBP (mm Hg) 117 ± 10
DBP (mm Hg) 77 ± 9
HR (beats/min) 70 ± 11
Table 2. Particle, O3, and environmental exposure
measures (mean ± SD; n = 23).
Measure CAP+O3 PFA
PM2.5 (µg/m3) 147 ± 27* 2 ± 2
O3 (ppb) 121 ± 3* 8 ± 5
NOx (ppb) 55 ± 18 51 ± 23
SO2 (ppb) 3 ± 2 4 ± 5
CO (ppm) 0.6 ± 0.2 0.5 ± 0.2
Temperature (°C) 23.0 ± 1.3 23.3 ± 1.3
Relative humidity (%) 49 ± 8 48 ± 9
NOx, nitrogen oxides.
*p < 0.0001, unpaired t-test for CAP+O3 versus PFA.
Table 3. Median (binomial 95% CI) DBP and SBP (mm Hg) over 2-hr exposures (n = 23).
Exposure time
0 hr 0.5 hr 1 hr 1.5 hr 2 hr 2 hr ∆a
CAP+O3
DBP 69 (65–75) 73 (68–79) 75 (72–76) 75 (70–76) 78 (71–82) 6 (0–11)*#
SBP 118 (112–127) 117 (111–126) 119 (111–126) 118 (112–124) 121 (113–124) –1 (–5–4)
PFA
DBP 74 (69–78) 73 (71–76) 72 (68–78) 76 (70–81) 73 (70–76) 1 (–2–4)
SBP 117 (113–124) 115 (107–121) 118 (110–123) 120 (114–131) 121 (112–123) 0 (–2–5)
a2-hr – 0-hr linear change. *p = 0.013 for CAP+O3 DBP 2 hr ∆, Wilcoxon signed rank test. #p = 0.017 for CAP+O3 DBP 2 hr ∆
versus PFA DBP 2 hr ∆, Wilcoxon signed rank test.p = 0.35). A weaker correlation was shown
between SBP and ln organic carbon (r = 0.45,
p = 0.031) but not with total mass (r = 0.05,
p = 0.83).
Discussion
For individuals exposed to CAP+O3 for 2 hr,
we observed a signiﬁcant increase of 6 mm Hg
(9.3%) in DBP. A particularly interesting
ﬁnding is the strong association between the
size of the 2-hr DBP change (and MAP) and
the carbon content of the ﬁne particles. This
result provides additional validity and biologic
plausibility to the observed blood pressure
increase. The levels of both pollutants in this
study, although high, were at environmentally
relevant concentrations [U.S. Environmental
Protection Agency (EPA) 2002]. These ﬁnd-
ings shed further light upon the biologic
mechanisms that link air pollution exposure to
enhanced cardiovascular risk.
The significant correlation between the
organic carbon fraction of the PM2.5 and BP
change suggests that PM composition is an
important factor in cardiovascular health
effects and that the carbonaceous fraction in
particular warrants further study. It is also pos-
sible that carbon is only a measurement proxy
for the pollutant actually responsible. A source
apportionment study of local ambient PM2.5,
over the same time period, has shown that
40–50% of the organic carbon was motor
vehicle related—through either combustion or
road dust (Lee et al. 2003). Exposure to urban
traffic has been identified as a potential risk
factor for cardiovascular disease (Peters and
Pope 2002). Of particular note, a recent study
reported an association between exposure to
urban traffic and the onset of myocardial
infarction, as soon as 1 hr afterward (Peters
et al. 2004). Although we observed no associa-
tion between other pollutants (e.g., O3) and
the change in BP, further studies will be
required to clarify the specific pollutant(s)
responsible. In particular, studies will need to
be performed using concentrated particles with
and without added O3 to determine if there are
important additive or synergistic interactions.
Of substantial interest is that three epi-
demiologic studies have previously demon-
strated associations between air pollution and
elevated BP (Ibald-Mulli et al. 2001; Linn
et al. 1999; Zanobetti et al. 2004). However,
the findings of our study, using a controlled
experimental design, greatly strengthen the
evidence that air pollution actually plays a
causal role in elevating BP.
Several published controlled human expo-
sure studies have not reported a significant
increase in DBP after exposures to ﬁne CAP
(Gong et al. 2003), ﬁne CAP+O3 (Brook et al.
2002), diesel exhaust particles (Nightingale
et al. 2000), or O3 (Gong et al. 1998). Gong
et al. (1998) did, however, report a signiﬁcant
increase in the rate pressure product (SBP ×
HR) and HR after O3 exposure compared
with ﬁltered air, although the dose of O3 the
subjects were exposed to (300 ppb for 3 hr
with intermittent exercise, 30–40 L/min) was
at least 12 times higher than in our study
(120 ppb for 2 hr without exercise). It is prob-
able that other experimental differences at least
partially explain the disparity between the pre-
sent and previous reports. For example, as far
as we are aware, the hemodynamic responses
(in the aforementioned four controlled human
exposure studies) have previously been
reported only before and several minutes after
exposures. The accurate determination of any
pollutant-induced alteration in BP was likely
hindered by temperature and pressure changes,
physical exertion, and the probable time delay
(several minutes) during patient transport from
the exposure facility to the site of physiologic
measurements. Our present study design mini-
mized some of these confounding variables, by
performing repeated measurements of BP dur-
ing the actual exposure period using an auto-
mated oscillometric device while resting
stationary in the enclosure.
At present, the precise pathophysiologic
mechanisms of the BP increase remain specula-
tive. It is possible that, through activation of
lung macrophages or alveolar cells after cellular
uptake and/or via interaction with the cell
membranes, inhaled pollutants (particles/O3)
could promote systemic oxidative stress
(Donaldson et al. 2003; Kelly 2003). Induction
of systemic oxidative stress (Gurgueira et al.
2002; Sorensen et al. 2003) and a pro-
inﬂammatory response (Salvi et al. 1999; Tan
et al. 2000) may alter the bioavailability of
nitric oxide within the vasculature and/or by
increasing several vasoconstrictive factors, such
as endothelin (Taniyama and Griendling 2003;
Vincent et al. 2001) or asymmetric dimethyl-
arginine (Cooke 2000; Dvonch et al. 2004).
Indeed, enhanced oxidative stress and systemic
inﬂammation are known to play a key role in
the pathophysiology of many cardiovascular
diseases, in particular, hypertension (Oparil
et al. 2003). An imbalance of the autonomic
nervous system favoring an increase in sympa-
thetic drive (Devlin et al. 2003; Gold et al.
2000; Magari et al. 2001) may also contribute
to this hypertensive response.
The risks for myocardial infarctions
(Peters et al. 2001, 2004), as well as strokes
(Hong et al. 2002; Tsai et al. 2003), increase
in response to acute elevations in air pollution.
These observations suggest that a factor com-
mon to the etiology of both adverse outcomes,
such as an elevated BP, may play a signiﬁcant
pathophysiologic role. It is well established
that relatively small sustained increases in
DBP even within the normotensive range, as
observed in this study (median change of
6 mm Hg), increase the long-term risk for
coronary events and strokes by approximately
30% and 40%, respectively (Lewington et al.
2002; Vasan et al. 2001). However, the
cardiovascular risk imposed by the brief vaso-
pressor response observed in this study is less
certain. Nevertheless, two hypothetical scenar-
ios may be envisioned. Exposure to high
ambient concentrations of air pollutants may
initiate a rapid hypertensive response, thus
promoting acute cardiovascular events in sus-
ceptible individuals. In conjunction, if this
vasopressor response continues unabated, gra-
dients in personal exposure to air pollution
could contribute to long-term differences in
interindividual BP levels. Continued exposure
to air pollution could thereby increase the risk
for developing chronically elevated BP and
possibly overt hypertension.
Conclusions
We observed a rapid and a statistically signiﬁ-
cant increase of diastolic BP among individuals
exposed to ambient fine particles and O3.
Lending biologic plausibility to this observa-
tion is that the size of the 2-hr change in blood
pressure is associated with the carbon content
of the fine particles. Although this may help
explain the mechanisms whereby air pollution
increases cardiovascular risk, the clinical signiﬁ-
cance of this finding, the responsible pollu-
tants, biologic mechanisms, and the duration
of the response require further investigation.
Exposure to vehicular trafﬁc in urban centers
may provide a common link between our ﬁnd-
ings and previous studies in which this expo-
sure source was identified as a potential risk
factor for cardiovascular disease.
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